A new government report finds 40% of U.S. counties didn’t have a single healthcare provider approved to prescribe the opioid addiction medication buprenorphine in 2018.
A new study finds more than two-thirds of teens and young adults who survive an opioid overdose don’t receive treatment for their addiction within 30 days.
A judge ruled Wednesday that a Philadelphia group’s plan to run a supervised drug injection site does not violate federal drug laws, The New York Times reports.
Medication used to treat opioid addiction can be helpful for teens who misuse opioids, a new study suggests. Until now, the evidence for the effectiveness of medication-assisted treatment in teens has been unclear, HealthDay reports.
A change proposed by the Department of Health and Human Services that would give doctors greater access to addiction treatment records is raising patient privacy concerns, PBS NewsHour reports.
More Medicare patients are receiving medication-assisted treatment for opioid use disorder, according to a new report by the Department of Health and Human Services.
A new study using “secret shoppers” found patients who are uninsured or covered by Medicaid often have a difficult time getting an appointment with a doctor who prescribes the opioid addiction medication buprenorphine.
A study of outpatient treatment for opioid addiction finds white patients are almost 35 times more likely than black patients to have a visit related to the addiction treatment medication buprenorphine, Kaiser Health News reports.
The National Institutes of Health will fund a study aimed at reducing opioid overdose deaths by 40 percent in three years, The Washington Post reports. The study will be conducted in four states hard hit by the opioid crisis.
Family involvement is a key component to success in treatment for teen substance use disorder, according to a review of recent research by an expert at the Center on Addiction.
Medicaid expansion has led to increases in the number of people diagnosed with and treated for opioid addiction, according to a new study that focused on West Virginia.
Certain insurance plans are legally required to cover benefits for addiction treatment under the Affordable Care Act (ACA). A new report by Center on Addiction shows that ACA Plans sold in many states in 2017 did not comply with these requirements.
Few teens addicted to painkillers receive treatment, a new analysis of federal data finds. Youths of color are especially unlikely to receive treatment.
A new study finds spending on prescriptions for the treatment of opioid use disorder and overdose increased faster in states that expanded Medicaid, according to U.S. News & World Report.
The U.S. Food and Drug Administration (FDA) has issued a new round of warnings and advisory letters to makers of dietary supplements, telling them not to falsely claim their products cure, prevent or treat serious diseases. Last year the FDA and the Federal Trade Commission sent warning letters to makers and distributors of 12 products sold as treatments for opioid addiction and withdrawal.
A new study finds only 36 percent of outpatient facilities that treat substance use disorder offer medication-assisted treatment for opioid use disorder.
A new federal program will help pay back student loans for addiction treatment providers who are willing to work in high-need, underserved areas, according to U.S. News & World Report.
The number of private insurance claims for treatment of substance use disorders and mental health conditions has skyrocketed in the last 10 years, according to a new report.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
